SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Blueprint Medicines Corporation (BPMC)

Add BPMC Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 6/5/2016 12:43:36 PM - Followers: 4 - Board type: Free - Posts Today: 0
Blueprint Medicines is a patient-driven oncology company developing highly selective kinase inhibitors for genomically defined cancer subsets. Led by a management team and advisors with world-renowned expertise in cancer genomics, drug discovery and clinical oncology, Blueprint has developed a platform that combines genomics with a novel library of kinase inhibitors, enabling Blueprint to rapidly develop potent highly selective compounds against clear genomic driver targets.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
BPMC News: Statement of Changes in Beneficial Ownership (4) 10/17/2016 05:43:55 PM
BPMC News: Statement of Changes in Beneficial Ownership (4) 10/04/2016 06:24:19 PM
BPMC News: Confidential Treatment Order (ct Order) 09/19/2016 05:25:12 PM
BPMC News: Initial Statement of Beneficial Ownership (3) 09/12/2016 08:15:40 AM
BPMC News: Blueprint Medicines Announces New Drug Discovery Program Targeting PRKACA Kinase Fusions for the Treatment of Fibrolamellar C... 09/09/2016 08:30:00 AM